These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15287520)

  • 1. [Human vascular lesions and thrombosis].
    Fujino H
    Rinsho Ketsueki; 2004 Jun; 45(6):449-53. PubMed ID: 15287520
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary, carotid and iliac femoral atherothrombotic lesions. Similarities and differences].
    Arbustini E
    Minerva Cardioangiol; 1999 Nov; 47(11):363-4. PubMed ID: 10641396
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemokines in atherosclerosis, thrombosis, and vascular biology.
    Weber C
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1896. PubMed ID: 18946056
    [No Abstract]   [Full Text] [Related]  

  • 4. A device for the production of well-defined lesions of mesenteric blood vessels with resulting platelet thrombi.
    Reber K
    Thromb Diath Haemorrh; 1966 May; 15(3):471-5. PubMed ID: 5989031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical pathology of thrombosis (author's transl)].
    Fujimaki M
    Rinsho Byori; 1973 Nov; 21(11):877-8. PubMed ID: 4798403
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vascular changes of the penis in advanced age (author's transl)].
    Sierra-Callejas JL; Gotthardt K
    Verh Dtsch Ges Pathol; 1975; 59():357-9. PubMed ID: 1217041
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of oxidative modifications in atherosclerosis.
    Stocker R; Keaney JF
    Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial damage and thrombosis.
    Spaet TH; Gaynor E
    Adv Cardiol; 1970; 4():47-66. PubMed ID: 4924085
    [No Abstract]   [Full Text] [Related]  

  • 10. The pleiotropic effect of statins in haemodialysis patients is not the consequence of an inhibition of LDL oxidation by myeloperoxidase.
    Van Antwerpen P; Boudjeltia KZ; Vaes M; Babar S; Madhoun P; Moguilevsky N; Vanhaeverbeek M; Néve J; Ducobu J
    Nephrol Dial Transplant; 2006 Sep; 21(9):2672-4. PubMed ID: 16574674
    [No Abstract]   [Full Text] [Related]  

  • 11. Vascular lesions in euthyroid goiter.
    Milcu SM; Taşcă C; Stefăneanu L; Moisescu N; Tănăsescu G
    Endocrinologie; 1980; 18(1):29-34. PubMed ID: 7361068
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular bed-specific thrombosis.
    Aird WC
    J Thromb Haemost; 2007 Jul; 5 Suppl 1():283-91. PubMed ID: 17635738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise, C-reactive protein, and your heart.
    Harv Mens Health Watch; 2005 Jul; 9(12):1-4. PubMed ID: 16161240
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycation as an atherogenic modification of LDL.
    Younis N; Sharma R; Soran H; Charlton-Menys V; Elseweidy M; Durrington PN
    Curr Opin Lipidol; 2008 Aug; 19(4):378-84. PubMed ID: 18607185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stent pathology--should we still be cautious?
    Nakazawa G; Finn AV; Virmani R
    Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):1. PubMed ID: 18094669
    [No Abstract]   [Full Text] [Related]  

  • 16. Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis prevention.
    Parhofer KG
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):414-7. PubMed ID: 16151973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant effect of polyphenolic glabridin on LDL oxidation.
    Carmeli E; Fogelman Y
    Toxicol Ind Health; 2009; 25(4-5):321-4. PubMed ID: 19651803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term exercise a better bet to protect arteries.
    Harv Heart Lett; 1998 Sep; 9(1):7. PubMed ID: 9734247
    [No Abstract]   [Full Text] [Related]  

  • 19. LDL susceptibility to oxidation and HDL antioxidant capacity in patients with renal failure.
    Jurek A; Turyna B; Kubit P; Klein A
    Clin Biochem; 2006 Jan; 39(1):19-27. PubMed ID: 16309663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of leptin are associated with the plasma levels of LDL conjugated dienes in children.
    Shin MJ; Park E
    Ann Nutr Metab; 2007; 51(1):1-6. PubMed ID: 17259698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.